| |
NYS DURB Recommendations - Sept 15 2016
|
| |
| |
Download the PDF here
Preferred
Epclusa(forgenotypes2 & 3), Harvoni, ribavirin, Technivie,Viekira Pak,Viekira XR,Zepatier [Applies to Fee For Service]
Non-preferred
Copegus, Daklinza, Moderiba, Olysio, Rebetol, Ribasphere, Sovaldi
Commissioner still needs to approve these recommendations. Therefore, they are not final. When they are final, they will be posted in a Medicaid Update.
New York State Medicaid Drug Utilization Review (DUR) Board
Meeting Summary for September 15, 2016
The Medicaid DUR Board met on Thursday, September 15, 2016 from 9:00 AM to 4:00 PM
Meeting Room 6, Concourse, Empire State Plaza, Albany, New York
An archived audio cast of the meeting proceedings is available on the Department of Health website:
https://www.health.ny.gov/events/webcasts/2016/2016-09-15_dur.htm
The meeting summary from the Drug Utilization Board meeting, held on September 15, 2016, has been posted to the DOH web-site.
http://www.health.ny.gov/health_care/medicaid/program/dur/meetings/2016/09/summary_durb.pdf
|
|
| |
| |
|
|
|
